Rate, degree, and predictors of recovery from disability following ischemic stroke

被引:125
作者
Hankey, G. J.
Spiesser, J.
Hakimi, Z.
Bego, G.
Carita, P.
Gabriel, S.
机构
[1] Royal Perth Hosp, Stroke Unit, Dept Neurol, Perth, WA 6001, Australia
[2] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia
[3] Sanofi Aventis Rech & Dev, Bagneux, France
关键词
D O I
10.1212/01.wnl.0000260967.77422.97
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the rate, degree, and predictors of recovery from disabling ischemic stroke. Methods: Patients with ischemic stroke enrolled in the Management of Atherothrombosis With Clopidogrel in High-Risk Patients ( MATCH) study underwent long-term prospective assessment of their modified Rankin Scale (mRS) score. Disability (functionally dependent state) was defined as mRS >= 3, and recovery (functionally independent state) was defined as mRS < 3. The timing and the independent predictors of recovery were determined using a Cox proportional hazards multiple regression analysis. Results: Of 7,599 patients enrolled with ischemic stroke or TIA, 1,662 (21.8%) were disabled (mRS >= 3) at baseline (median of 14 [0 to 96] days after stroke onset). Disability was moderate (mRS 3) in 931 (56%) patients, severe (mRS 4) in 691 (42%), and very severe (mRS 5) in 40 (2%). By 18 months, 877 (52.8%, 95% CI 50% to 55%) patients had recovered, 589 (63%, 60% to 66%) with moderate disability, 281 (41%, 37% to 44%) with severe disability, and 7 (17%, 7 to 33%) with very severe disability. Median time to recovery was 3 months for patients with moderate disability and 18 months for severe disability; 82.5% of severely disabled patients remained so at 18 months. Predictors of recovery were moderate disability (mRS 3) at baseline compared with severe (mRS 4: hazard ratio [HR] 2.13, 1.86 to 2.44) or very severe disabling stroke (HR 5.88, 2.86 to 12.5); younger women (aged <65 years, compared with >= 75 years; HR 1.85, 1.47 to 2.33); decreasing time (days) between the qualifying event and the baseline assessment (HR 1.01, 1.01 to 1.02); and the absence of previous ischemic stroke (HR 1.61, 1.35 to 1.92), concurrent peripheral artery disease (HR 1.61, 1.23 to 2.13), or diabetes (HR 1.30, 1.10 to 1.54). Conclusions: Half of patients with disabling ischemic stroke recovered within 18 months, and recovery was greatest within 6 months. Significant predictors of recovery included the severity of the index stroke and no history of ischemic stroke, peripheral artery disease, or diabetes.
引用
收藏
页码:1583 / 1587
页数:5
相关论文
共 16 条
  • [1] Poor outcome after first-ever stroke - Predictors for death, dependency, and recurrent stroke within the first year
    Appelros, P
    Nydevik, I
    Viitanen, M
    [J]. STROKE, 2003, 34 (01) : 122 - 126
  • [2] Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
    Bath, PMW
    Lindenstrom, E
    Boysen, G
    De Deyn, P
    Friis, P
    Leys, D
    Marttila, R
    Olsson, JE
    O'Neill, D
    Orgogozo, JM
    Ringelstein, B
    van der Sande, JJ
    Turpie, AGG
    [J]. LANCET, 2001, 358 (9283) : 702 - 710
  • [3] Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    Diener, HC
    Bogousslavsky, J
    Brass, LM
    Cimminiello, C
    Csiba, L
    Kaste, M
    Leys, D
    Matias-Guiv, J
    Rupprecht, HJ
    [J]. LANCET, 2004, 364 (9431) : 331 - 337
  • [4] Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): Study design and baseline data
    Diener, HC
    Bogousslavsky, J
    Brass, LM
    Cimminiello, C
    Csiba, L
    Kaste, M
    Leys, D
    Matias-Guiu, J
    Rupprecht, HJ
    [J]. CEREBROVASCULAR DISEASES, 2004, 17 (2-3) : 253 - 261
  • [5] DISABILITY AND USE OF REHABILITATION SERVICES FOLLOWING STROKE IN ROCHESTER, MINNESOTA, 1975-1979
    DOMBOVY, ML
    BASFORD, JR
    WHISNANT, JP
    BERGSTRALH, EJ
    [J]. STROKE, 1987, 18 (05) : 830 - 836
  • [6] Defining post-stroke recovery: implications for design and interpretation of drug trials
    Duncan, PW
    Lai, SM
    Keighley, J
    [J]. NEUROPHARMACOLOGY, 2000, 39 (05) : 835 - 841
  • [7] THE UNITED-KINGDOM TRANSIENT ISCHEMIC ATTACK (UK-TIA) ASPIRIN TRIAL - FINAL RESULTS
    FARRELL, B
    GODWIN, J
    RICHARDS, S
    WARLOW, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (12) : 1044 - 1054
  • [8] Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990
    Hankey, GJ
    Jamrozik, K
    Broadhurst, RJ
    Forbes, S
    Anderson, CS
    [J]. STROKE, 2002, 33 (04) : 1034 - 1040
  • [9] Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study
    Hardie, K
    Hankey, GJ
    Jamrozik, K
    Broadhurst, RJ
    Anderson, C
    [J]. STROKE, 2004, 35 (03) : 731 - 735
  • [10] KADOJIC D, 2000, ACTA CLIN CROAT, V39, P277